Literature DB >> 16696335

Construction of antisense MT1-MMP vector and its inhibitory effects on invasion of human ovarian cancer cells.

Mingfu Wu1, Yanyan Shi, Lin Xi, Qiong Li, Guo-Nin Liao, Zhi-Qiang Han, Yun-Ping Lu, Ding Ma.   

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP-14) plays crucial roles in tumor cell growth, invasion, and angiogenesis. To clarify whether the endogenously expressed MT1-MMP in metastatic human ovarian carcinoma cell lines SKOV3 plays a critical role in tumor cell invasiveness, antisense MT1-MMP cloned in eukaryotic expression vector pMMP14as was transferred into SKOV3 cells. 48h after transfection, decreased expression of endogenous MT1-MMP protein was detected in pMMP14as-transfected SKOV3 cells and the activation of pro-MMP2 was inhibited markedly. The mean percentage of invasive cells was (62.50 +/- 5.30) % in pMMP14as-transfected cells, which was obviously less than that (97.20 +/- 6.90) % in the control. Thus, antisense MT1-MMP effectively inhibited the endogenous MT1-MMP expression and the invasiveness in SKOV3 cells, suggesting that MT1-MMP may be a therapeutic target molecule for human invasive ovarian cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16696335     DOI: 10.1007/bf02896180

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

2.  MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.

Authors:  N E Sounni; L Devy; A Hajitou; F Frankenne; C Munaut; C Gilles; C Deroanne; E W Thompson; J M Foidart; A Noel
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

3.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

Review 4.  Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

Authors:  Motoharu Seiki
Journal:  Cancer Lett       Date:  2003-05-08       Impact factor: 8.679

5.  Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system.

Authors:  Dmitri V Rozanov; Alexei Y Savinov; Vladislav S Golubkov; Tatiana I Postnova; Albert Remacle; Stephen Tomlinson; Alex Y Strongin
Journal:  J Biol Chem       Date:  2004-09-14       Impact factor: 5.157

Review 6.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.

Authors:  Laura E Graves; Edgardo V Ariztia; Jason R Navari; Heather J Matzel; M Sharon Stack; David A Fishman
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.

Authors:  Junko Ueda; Masahiro Kajita; Naoko Suenaga; Katsuyuki Fujii; Motoharu Seiki
Journal:  Oncogene       Date:  2003-11-27       Impact factor: 9.867

9.  Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

Authors:  K Hotary; E Allen; A Punturieri; I Yana; S J Weiss
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

  9 in total
  1 in total

1.  The role of MMP-14 in ovarian cancer: a systematic review.

Authors:  M Caroline Vos; Anneke A M van der Wurff; Toin H van Kuppevelt; Leon F A G Massuger
Journal:  J Ovarian Res       Date:  2021-08-03       Impact factor: 4.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.